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Background
Dynamic-MRI is the gold-standard to evaluate the early
involvement of the sacroiliac joints in patients with
enthesitis-related arthritis (ERA).
Aim
In our study, this method was also used to define the
evolution over time of sacroiliitis (SI) and to evaluate
the response to therapy.
Methods
A retrospective chart review for all patients with SI fol-
lowed in our Unit since 2006 was performed. In all these
patients the clinical, laboratory and instrumental follow-up
was evaluated using dynamic contrast-enhanced MRI with
fat suppression technique (STIR), in order to assess the
radiological outcome and response to therapy.
Results
47 patients (29 M, 18F), complained of inflammatory
back pain, after a mean interval of 9 months (range 0 –
4 yrs11 m) from disease onset. In all symptomatic pts
dynamic MRI of the sacroiliac joints was performed,
and was positive in 28/47 (17 M, 11 F). We identified
25 pts with grade I SI (5 unilateral and 20 bilateral),
1 pt with grade II bilateral SI, and 2 pts with grade 2/I
SI (right/left). In 16 patients (57%) treatment with sul-
phasalazine (SSZ) was started, in 11 (39%) with NSAIDs
only, and in one with Adalimumab.
After 1 year, 12 pts remained symptomatic and MRI
was repeated, and 6 still had radiological signs of SI,
including 5 with bilateral SI grade I and one with grade
II/I SI. They were on treatment with NSAIDs (n=2) and
SSZ (n=4); the 6 pts in which MRI was negative were
also treated with NSAIDs (n=2) and SSZ (n=4). Three
of them still had a positive MRI after 2 years (all on
SSZ).
Conclusions
Dynamic contrast-enhanced MRI is useful not only to
identify early involvement of sacroiliitis in patients with
symptomatic ERA, but also to evaluate the course of the
disease and response to therapy. Although SSZ is a
commonly used drug for the treatment of SI, it was
effective only in few of our cases.
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